Sampo raises 2026 underwriting profit outlook on strong Q1

Sampo raised its full-year 2026 underwriting profit outlook to €1,525-1,625 million from €1,485-1,600 million, while also lifting premium income guidance to €9.6-9.8 billion. Q1 underwriting profit rose 9% to €368 million and the combined ratio held at a strong 84.4%, supported by lower weather claims and fewer large losses. The company also announced a €350 million share buyback, partly funded by 2025 operating profit and the planned sale of NOBA shares.

Analysis

The key signal is not the modest upgrade itself, but the quality of the earnings beat: lower cat losses and fewer large claims are exactly the kind of favorable variance that tends to mean-revert. That makes the revised guidance credible near-term, but it also means the market should be careful about extrapolating this quarter’s margin profile into the back half of the year, especially if Nordic weather normalizes or reserve releases fade.

The bigger second-order implication is capital allocation. A fresh buyback at a still-healthy solvency ratio effectively converts underwriting stability into per-share growth, and that should keep the stock supported even if premium growth remains mid-single digit. The limitation is that the upside is increasingly financial-engineering driven; if investment markets stay volatile, headline net income can remain noisy and obscure operating improvement.

From a competitive lens, the firm is likely taking share in lower-risk retail and SME channels while larger commercial accounts stay more price-competitive and slower-growing. That mix shift matters because it tends to improve loss experience and capital efficiency, but it also leaves less room for upside if peers decide to chase volume later in the cycle. The legal overhang looks manageable in reserve terms, yet the market may still penalize any sign that statutory or court-driven claims creep beyond current assumptions.

Consensus is probably underpricing the durability of capital return support relative to the uncertainty around reported net profit. The cleaner way to express the view is that this is a cash-return story with modest operating upside, not a compounding-growth story; that should anchor valuation in the near term, but limits multiple expansion unless underwriting discipline continues to surprise positively.

Key Decisions for Investors

• Long Sampo on 3-6 month horizon into buyback execution: favor a low-volatility, capital-return-supported name with limited downside unless claims normalize sharply; add on any post-earnings weakness rather than chasing strength.
• Pair trade: long Sampo / short a Nordic insurer with higher market sensitivity and weaker capital return visibility over 1-2 quarters; the relative trade should benefit if investors continue rewarding underwriting quality plus buybacks.
• Use call spreads rather than outright equity if entering now: 3-6 month upside is likely capped unless another quarter confirms favorable claims and reserve dynamics, so defined-risk convexity is preferable to paying for full delta.
• Trim or hedge if solvency slips toward the low-170s or if weather-loss commentary turns adverse into summer/fall: that would challenge the market’s willingness to capitalize buybacks at current multiples.